Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12611423 | Medical use of tafoxiparin | 🖼🧊📄§ | 2026-04-28 | 2043-05-02 | 0 | 31 |
| 12612463 | Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors | 🖼🧊📄§ | 2026-04-28 | 2044-01-19 | 0 | 31 |
| 12612462 | Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding IL33 and IL1RL1 | 🖼🧊📄§ | 2026-04-28 | 2043-06-07 | 0 | 31 |
| 12612460 | Anti-PD-1 antibodies and fusion proteins | 🖼🧊📄§ | 2026-04-28 | 2044-12-20 | 0 | 31 |
| 12612389 | Benzofuran-based N-acylhydrazone derivative and pharmaceutical composition comprising same | 🖼🧊📄§ | 2026-04-28 | 2040-07-14 | 0 | 31 |
| 12611456 | Use of thiazole amide compounds for modulating human immune response | 🖼🧊📄§ | 2026-04-28 | 2040-09-16 | 0 | 31 |
| 12611460 | Eyedrop compositions | 🖼🧊📄§ | 2026-04-28 | 2039-09-18 | 0 | 31 |
| 12611379 | Lipid nano drug delivery system targeting brain lesion and preparation method and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-13 | 0 | 31 |
| 12611381 | Cationic hyaluronic acid coated spanlastics and preparation and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-04-02 | 0 | 31 |
| 12611400 | Solid lipid nano-composition containing berberine and cinnamonaldehyde effective in treating diabetes, dyslipidemia, and method of preparing the same | 🖼🧊📄§ | 2026-04-28 | 2040-12-04 | 0 | 31 |
| 12611428 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-04-28 | 2040-12-02 | 0 | 31 |
| 12611443 | Methods and compositions related to therapeutic peptides for cancer therapy | 🖼🧊📄§ | 2026-04-28 | 2041-06-14 | 0 | 31 |
| 12612375 | Antimicrobial and anticancer agents | 🖼🧊📄§ | 2026-04-28 | 2042-04-28 | 0 | 31 |
| 12612627 | Compositions and methods for increasing sodium current in cardiac cells | 🖼🧊📄§ | 2026-04-28 | 2041-04-19 | 0 | 31 |
| 12612629 | Duchenne muscular dystrophy-related exonic splicing enhancer, sgRNA and gene editing tool, and applications | 🖼🧊📄§ | 2026-04-28 | 2040-09-30 | 0 | 31 |
| 12612610 | Compositions and methods for controlling blood pressure | 🖼🧊📄§ | 2026-04-28 | 2042-11-11 | 0 | 31 |
| 12605472 | Radiolabeling of anti-CD45 immunoglobulin and methods of use thereof | 🖼🧊📄§ | 2026-04-21 | 2040-09-17 | 0 | 31 |
| 12605463 | Tolerogenic artificial antigen-presenting cells | 🖼🧊📄§ | 2026-04-21 | 2040-06-12 | 0 | 31 |
| 12605455 | CAR peptide for improved coronavirus survival | 🖼🧊📄§ | 2026-04-21 | 2041-03-19 | 0 | 31 |
| 12605456 | Composition and method for HIP1-targeting inhibitor compounds | 🖼🧊📄§ | 2026-04-21 | 2042-05-28 | 0 | 31 |
| 12605442 | Production of vaccines comprising inactivated SARS-CoV-2 viral particles | 🖼🧊📄§ | 2026-04-21 | 2041-03-05 | 0 | 31 |
| 12605439 | Universal influenza vaccine compositions | 🖼🧊📄§ | 2026-04-21 | 2041-12-28 | 0 | 31 |
| 12605437 | Single shot Chikungunya virus vaccine | 🖼🧊📄§ | 2026-04-21 | 2040-08-10 | 0 | 31 |
| 12605429 | Proteins having pneumococcal capsule degrading activity and methods of use | 🖼🧊📄§ | 2026-04-21 | 2043-05-19 | 0 | 31 |
| 12605457 | Modified EGFR antibody with reduced affinity, drug conjugate, and use thereof | 🖼🧊📄§ | 2026-04-21 | 2041-11-19 | 0 | 31 |
| 12605433 | Antibody specifically binding to PTK7 and use thereof | 🖼🧊📄§ | 2026-04-21 | 2041-07-16 | 0 | 31 |
| 12605353 | PDIA4 inhibitors and use thereof for inhibiting β-cell pathogenesis and treating diabetes | 🖼🧊📄§ | 2026-04-21 | 2040-11-15 | 0 | 31 |
| 12605354 | Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions | 🖼🧊📄§ | 2026-04-21 | 2041-02-19 | 0 | 31 |
| 12605356 | Methods of treating pancreatic cancer | 🖼🧊📄§ | 2026-04-21 | 2043-10-26 | 0 | 31 |
| 12605361 | Carboxylated psilocybin derivatives and methods of using | 🖼🧊📄§ | 2026-04-21 | 2043-07-28 | 0 | 31 |
| 12605362 | Eletriptan hydrobromide for treatment of spinal cord injury and improvement of locomotor function | 🖼🧊📄§ | 2026-04-21 | 2040-12-21 | 0 | 31 |
| 12605380 | Methods of improving lung function | 🖼🧊📄§ | 2026-04-21 | 2045-09-12 | 0 | 31 |
| 12605375 | Use of CSF-1R kinase inhibitor | 🖼🧊📄§ | 2026-04-21 | 2041-02-26 | 0 | 31 |
| 12605376 | Methods of treating relapsing multiple sclerosis using an inhibitor of Bruton's tyrosine kinase | 🖼🧊📄§ | 2026-04-21 | 2041-04-01 | 0 | 31 |
| 12605392 | Cannabinoid composition and method of treating diabetic and chemotherapy induced neuropathic pain | 🖼🧊📄§ | 2026-04-21 | 2042-06-20 | 0 | 31 |
| 12605390 | Treatment of cancer and inhibition of metastasis | 🖼🧊📄§ | 2026-04-21 | 2041-10-27 | 0 | 31 |
| 12605417 | Compositions and methods for ameliorating symptoms associated with inflammatory skin disorders | 🖼🧊📄§ | 2026-04-21 | 2044-09-27 | 0 | 31 |
| 12605401 | Polymers, compositions and methods for treating hyperuricemia | 🖼🧊📄§ | 2026-04-21 | 2042-05-18 | 0 | 31 |
| 12605428 | Kinase NEK10 and its use in treating and diagnosing bronchiectasis and other respiratory disorders | 🖼🧊📄§ | 2026-04-21 | 2041-01-19 | 0 | 31 |
| 12605421 | Senescence inhibitor | 🖼🧊📄§ | 2026-04-21 | 2045-03-18 | 0 | 31 |
| 12605420 | Use of plant composition, traditional Chinese medicine composition in preparing medicine for treating COVID-19 | 🖼🧊📄§ | 2026-04-21 | 2042-10-19 | 0 | 31 |
| 12605419 | Flavonoid extract of Cyclocarya paliurus leaves and antibacterial drugs and/or antibacterial agents containing thereof | 🖼🧊📄§ | 2026-04-21 | 2040-08-20 | 0 | 31 |
| 12605425 | TNF muteins and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-06-26 | 0 | 31 |
| 12605423 | Peptide inhibitors targeting methyltransfer mechanism of SARS-CoV-2 | 🖼🧊📄§ | 2026-04-21 | 2041-09-08 | 0 | 31 |
| 12605424 | Treatment and prevention of pulmonary injury | 🖼🧊📄§ | 2026-04-21 | 2040-09-04 | 0 | 31 |
| 12605431 | Composition for treating or preventing myopathy, obesity or diabetes | 🖼🧊📄§ | 2026-04-21 | 2041-12-14 | 0 | 31 |
| 12605458 | Antibody-drug conjugate having acidic self-stabilization junction | 🖼🧊📄§ | 2026-04-21 | 2038-06-15 | 0 | 31 |
| 12605413 | Engineered probiotics for treatment and immunity against viruses | 🖼🧊📄§ | 2026-04-21 | 2041-04-19 | 0 | 31 |
| 12605416 | Compositions and methods for the treatment of skin diseases and conditions including eczema | 🖼🧊📄§ | 2026-04-21 | 2044-12-27 | 0 | 31 |
| 12606572 | Substituted heterocycles and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2045-10-07 | 0 | 31 |